SoftBank Plans Billions to Invest in Biotech

SoftBank Group Corp. plans to expand its investments in the biotech and health-care sector, opening up a new front in its growing asset management strategy, according to people familiar with the matter. SoftBank has already made a clutch of equity investments in the sector, including a $312 million stake in Pacific Biosciences of California Inc., […]

Italy’s Angelini to buy Swiss biotech group for $1bn

Pharma company to get exclusive licence to commercialise epilepsy drug across EU, UK and Switzerland Italy’s Angelini Pharma has agreed to buy emerging Swiss biotech company Arvelle Therapeutics for up to $960m as it aims to become a leading European player in the treatment of central nervous system and mental diseases. Angelini will pay private-equity […]